A multifunctional PD-L1 modulator for metabolic reprogramming to induce pyroptosis and enhance glutamine inhibition-mediated antitumor immunotherapy
Fields of Study & Subjects
Nanoplatforms for cancer theranostics
Cancer
Hypoxia
and Metabolism
Immune cells in cancer
Publication details
- Journal / source
- Acta Biomaterialia
- Volume
- 212
- Pages
- 770–785
- Publication date
- 7 January 2026
- Language
- EN